PSA
56
3
YUM
43
-6
DAL
84
-3
A
37
-2
IBM
47
-3
EFX
30
-8
AIZ
82
2
KLAC
38
-6
WYNN
36
-5
ETN
75
-3
PEP
39
-9
CVS
41
-4
BDX
56
10
PEG
62
4
AXP
67
-2
F
56
-3
TGNA
50
-6
TSCO
44
-4
EOG
56
-2
BA
47
2
PSA
56
3
YUM
43
-6
DAL
84
-3
A
37
-2
IBM
47
-3
EFX
30
-8
AIZ
82
2
KLAC
38
-6
WYNN
36
-5
ETN
75
-3
PEP
39
-9
CVS
41
-4
BDX
56
10
PEG
62
4
AXP
67
-2
F
56
-3
TGNA
50
-6
TSCO
44
-4
EOG
56
-2
BA
47
2
Financhill
Back

Adverum Biotechnologies Vs. Editas Medicine Industry Stock Comparison

Sell
37

ADVM
Adverum Biotechnologies

Last Price:
6.85
Seasonality Move:
21.98%
Sell
40

EDIT
Editas Medicine

Last Price:
2.53
Seasonality Move:
7.77%
Sell
37
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.86. The Score for ADVM is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $2.66. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $2.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 35.85 Sell
Chaikin Money Flow: -179008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.47 - 8.17) Sell
Bollinger Bands (100): (6.82 - 7.98) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 35.77 Sell
Chaikin Money Flow: -833782 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.92 - 3.38) Sell
Bollinger Bands (100): (3.13 - 4.81) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.65 Sell
20-day SMA: 7.76 Sell
50-day SMA: 7.49 Sell
200-day SMA: 10.2 Sell
8-day EMA: 7.48 Sell
20-day EMA: 7.63 Sell
50-day EMA: 7.57 Sell
200-day EMA: 8.9 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.04 Sell
20-day SMA: 3.11 Sell
50-day SMA: 3.34 Sell
200-day SMA: 5.33 Sell
8-day EMA: 2.95 Sell
20-day EMA: 3.08 Sell
50-day EMA: 3.37 Sell
200-day EMA: 5.1 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):